| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.71B | +43.4% |
| Cost of Revenue | $1.17B | +10.2% |
| R&D Expense | $638.7M | +7.8% |
| SG&A Expense | $181.1M | +18.7% |
| Operating Income | $1.87B | +189.0% |
| Interest Expense | $318.3M | +15.5% |
| Pre-tax Income | $1.58B | +314.1% |
| Income Tax | -$3.8M | -115.8% |
| Net Income | $1.58B |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $741.4M | +47.6% |
| Accounts Receivable | $1.41B | +48.3% |
| Current Assets | $2.31B | +43.1% |
| Total Assets | $5.87B | +9.5% |
| Current Liabilities | $1.06B | +12.0% |
| Long-term Debt | $3.51B | +12.4% |
| Total Liabilities | $4.78B | +16.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.10B | +97.7% |
| Capital Expenditures | $4.8M | +12.5% |
| Investing Cash Flow | -$106.8M | -37.2% |
| Financing Cash Flow | -$1.75B | -12.0% |
| Free Cash Flow | $2.09B | +98.1% |
| +342.9% |
| EPS (Basic) | $4.68 | +363.4% |
| EPS (Diluted) | $4.53 | +362.2% |
| Stockholders' Equity |
| $1.09B |
| -13.3% |